Intravenous haloperidol for the treatment of intractable vomiting, cyclical vomiting, and gastroparesis

Brad E. Schwartz, Karen Keller Baker, Andrew J. Bleinberger, Amina Lleshi, Raul Cruz-Cano

Table 1 Hospitalization rate comparison between the non-IV HP group and the IV HP group

Parameters n Percentage P-value Total patients 24 a Hospitalized during non-IV HP visit 19 79.2% 0.003 Discharged after non-IV HP visit 5 20.8% Hospitalized during IV HP visit 8 33.3% Discharged after IV HP visit 16 66.7% Gastroparesis 12 a Hospitalized during non-IV HP visit 10 83.3% 0.036 Discharged after non-IV HP visit 2 16.7% Hospitalized during IV HP visit 4 33.3% Discharged after IV HP visit 8 66.7% Cyclical vomiting 3 a Hospitalized during non-IV HP visit 3 100.0% 0.100 Hospitalized during IV HP visit 0 0 Intractable vomiting 9 a Hospitalized during non-IV HP visit 6 66.7% 0.637 Discharged after non-IV HP visit 3 33.3% Hospitalized during IV HP visit 4 44.4 Discharged after IV HP visit 5 55.6%